Abstract
PURPOSE: This in vitro study evaluated the influence of different breathing patterns on the emitted dose of nebulized arformoterol. Breath simulation experiments used a PARI LC Plus® nebulizer in combination with the Dura-Neb 3000® portable aerosol system. Patterns were selected to mimic the ranges that might be observed in patients with chronic obstructive pulmonary disease (COPD).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
